• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    2/13/23 11:24:43 AM ET
    $ALLR
    $AMV
    $APM
    $AUID
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Automotive Aftermarket
    Consumer Discretionary
    Get the next $ALLR alert in real time by email

     

    On Monday, 42 companies hit new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Fisker (NYSE:FSR).
    • The smallest company on a market cap basis to set a new 52-week low was Tivic Health Systems (NASDAQ:TIVC).
    • Genius Brands Intl (NASDAQ:GNUS) was the biggest loser, trading down 724.9% to reach its 52-week low.
    • Celularity (NASDAQ:CELU)'s stock bounced back the most, actually rising 0.03% after reaching its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Monday:

    • Fisker (NYSE:FSR) shares hit a yearly low of $6.40. The stock was down 4.46% on the session.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.57. The stock traded up 1.34%.
    • Mineralys Therapeutics (NASDAQ:MLYS) stock broke to a new 52-week low of $17.58 on Monday. Shares of the company traded up 1.36%.
    • Lyell Immunopharma (NASDAQ:LYEL) shares hit a yearly low of $2.66. The stock was down 6.64% on the session.
    • Vertical Aerospace (NYSE:EVTL) shares hit a yearly low of $1.83. The stock was down 3.14% on the session.
    • Design Therapeutics (NASDAQ:DSGN) shares set a new 52-week low of $6.86. The stock traded down 1.85%.
    • Canoo (NASDAQ:GOEV) stock dropped to a yearly low on Monday of $0.92. Shares traded down 6.99%.
    • Sorrento Therapeutics (NASDAQ:SRNE) stock drifted down 37.36% on Monday morning to hit a new 52-week low of $0.50.
    • Ocugen (NASDAQ:OCGN) shares were down 1.34% for the day, having made a 52-week low of $1.08.
    • Nuburu (AMEX:BURU) stock hit $6.36 on Monday morning, setting a new 52-week low for a change of down 17.91%.
    • G1 Therapeutics (NASDAQ:GTHX) stock achieved a new 52-week low on Monday morning, hitting $3.20 and moving down 53.17%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) stock achieved a new 52-week low on Monday morning, hitting $1.04 and moving down 4.95%.
    • TOP Finl Gr (NASDAQ:TOP) shares moved down 0.97% on Monday to hit a new 52-week low of $3.50, drifting down 0.97%.
    • Bioventus (NASDAQ:BVS) shares were down 9.54% for the day, having made a 52-week low of $1.55.
    • Berkeley Lights (NASDAQ:BLI) shares reached a new 52-week low of $1.74 on Monday morning, moving down 5.41%.
    • Genius Brands Intl (NASDAQ:GNUS) shares were up 724.9% for the day, having made a 52-week low of $3.31.
    • Cumulus Media (NASDAQ:CMLS) stock set a new 52-week low of $6.01 on Monday, moving up 0.32%.
    • Yunji (NASDAQ:YJ) stock achieved a new 52-week low on Monday morning, hitting $0.51 and moving down 2.24%.
    • Gold Resource (AMEX:GORO) stock achieved a new 52-week low on Monday morning, hitting $1.08 and moving down 32.52%.
    • U.S. Xpress Enterprises (NYSE:USX) shares fell to $1.45 on Monday, setting a new 52-week low with a shift of down 1.32%.
    • Heliogen (NYSE:HLGN) shares set a new 52-week low of $0.37. The stock traded down 2.35%.
    • SeaStar Medical Holding (NASDAQ:ICU) stock hit a new 52-week low of $3.15. The stock was down 7.94% on the session.
    • Frequency Therapeutics (NASDAQ:FREQ) shares made a new 52-week low of $0.70 on Monday. The stock was down 78.93% for the day.
    • Lion Group Holding (NASDAQ:LGHL) stock set a new 52-week low of $0.46 on Monday, moving down 3.23%.
    • MGO Global (NASDAQ:MGOL) shares fell to $1.75 on Monday, setting a new 52-week low with a shift of up 2.17%.
    • Titan Medical (NASDAQ:TMDI) shares set a new 52-week low of $0.21. The stock traded down 9.31%.
    • IMV (NASDAQ:IMV) stock set a new 52-week low of $1.44 on Monday, moving down 15.15%.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares reached a new 52-week low of $1.88 on Monday morning, moving down 23.85%.
    • Aptorum Gr (NASDAQ:APM) stock dropped to a yearly low on Monday of $3.42. Shares traded down 4.44%.
    • WiSA Technologies (NASDAQ:WISA) shares reached a new 52-week low of $5.80 on Monday morning, moving down 5.34%.
    • AuthID (NASDAQ:AUID) shares fell to $0.37 on Monday, setting a new 52-week low with a shift of up 5.09%.
    • Reshape Lifesciences (NASDAQ:RSLS) stock hit a new 52-week low of $4.25. The stock was down 9.36% on the session.
    • OceanPal (NASDAQ:OP) shares moved up 0.07% on Monday to hit a new 52-week low of $0.62, drifting up 0.07%.
    • Inpixon (NASDAQ:INPX) stock dropped to a yearly low on Monday of $0.87. Shares traded up 3.01%.
    • OpGen (NASDAQ:OPGN) stock achieved a new 52-week low on Monday morning, hitting $1.33 and moving down 4.26%.
    • Allarity Therapeutics (NASDAQ:ALLR) stock drifted down 6.71% on Monday morning to hit a new 52-week low of $0.17.
    • My Size (NASDAQ:MYSZ) stock hit a yearly low of $1.71. The stock was up 3.47% for the day.
    • Tivic Health Systems (NASDAQ:TIVC) shares fell to $0.21 on Monday, setting a new 52-week low with a shift of down 1.91%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AMV
    $APM
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    Design Therapeutics Inc.
    $DSGN
    1/7/2026$18.00Outperform
    Oppenheimer
    Vertical Aerospace Ltd.
    $EVTL
    1/7/2026Outperform
    William Blair
    Lyell Immunopharma Inc.
    $LYEL
    12/9/2025$45.00Neutral → Buy
    H.C. Wainwright
    Design Therapeutics Inc.
    $DSGN
    12/3/2025$14.00Market Perform → Outperform
    Leerink Partners
    Design Therapeutics Inc.
    $DSGN
    12/3/2025$15.00Buy
    Craig Hallum
    Design Therapeutics Inc.
    $DSGN
    11/20/2025$13.00Sector Perform → Outperform
    RBC Capital Mkts
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    More analyst ratings

    $ALLR
    $AMV
    $APM
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Luzon Ronen bought $2,925 worth of shares (3,750 units at $0.78), increasing direct ownership by 1% to 293,085 units (SEC Form 4)

    4 - My Size, Inc. (0001211805) (Issuer)

    12/30/25 10:05:50 AM ET
    $MYSZ
    Computer Software: Prepackaged Software
    Technology

    Director Baird Jennifer A bought $987 worth of shares (4,200 units at $0.24), increasing direct ownership by 13% to 36,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/22/25 6:55:38 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Messinger Michael bought $5,098 worth of shares (14,500 units at $0.35), increasing direct ownership by 483% to 17,500 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/11/25 6:49:59 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ALLR
    $AMV
    $APM
    $AUID
    SEC Filings

    View All

    SEC Form 6-K filed by Aptorum Group Limited

    6-K - Aptorum Group Ltd (0001734005) (Filer)

    2/6/26 4:00:16 PM ET
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by OpGen Inc.

    DEF 14A - OPGEN INC (0001293818) (Filer)

    2/6/26 1:05:05 PM ET
    $OPGN
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Mineralys Therapeutics Inc.

    SCHEDULE 13G - Mineralys Therapeutics, Inc. (0001933414) (Subject)

    2/5/26 1:31:51 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AMV
    $APM
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Design Therapeutics with a new price target

    Oppenheimer initiated coverage of Design Therapeutics with a rating of Outperform and set a new price target of $18.00

    1/7/26 9:09:56 AM ET
    $DSGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Vertical Aerospace Group

    William Blair initiated coverage of Vertical Aerospace Group with a rating of Outperform

    1/7/26 8:35:04 AM ET
    $EVTL
    Aerospace
    Industrials

    Lyell Immunopharma upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Lyell Immunopharma from Neutral to Buy and set a new price target of $45.00

    12/9/25 8:34:46 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AMV
    $APM
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UPDATE – Westwood One Presents NFL Super Bowl LX Game-Day Coverage

    2026 Marks Westwood One's 53rd Super Bowl BroadcastKevin Harlan, Hall of Famer Kurt Warner, Gene Steratore, and Laura Okmin Call the Action Live from Santa ClaraScott Graham and Super Bowl Champion Ryan Harris Anchor Pregame, Halftime, and Postgame CoverageScott Graham and Ryan Harris to Interview NFL Commissioner Goodell During Pregame ShowMike Golic and Mike Golic Jr. Host the All-New Westwood One Tailgate Show Outside Levi's StadiumWestwood One Will Broadcast the Apple Music Super Bowl LX Halftime Show with Bad Bunny NEW YORK, Feb. 07, 2026 (GLOBE NEWSWIRE) -- Cumulus Media's (OTCQB:CMLS) Westwood One, one of America's largest audio networks and the exclusive national audio broadcaster

    2/7/26 3:25:54 PM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    Westwood One Presents NFL Super Bowl LX Game-Day Coverage

    2026 Marks Westwood One's 53rd Super Bowl BroadcastKevin Harlan, Hall of Famer Kurt Warner, Gene Steratore, and Laura Okmin Call the Action Live from Santa ClaraScott Graham and Super Bowl Champion Ryan Harris Anchor Pregame, Halftime, and Postgame CoverageScott Graham and Ryan Harris to Interview NFL Commissioner Goodell During Pregame ShowMike Golic and Mike Golic Jr. Host the All-New Westwood One Tailgate Show Outside Levi's StadiumWestwood One Will Broadcast the Apple Music Super Bowl LX Halftime Show with Bad Bunny NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cumulus Media's (OTCQB:CMLS) Westwood One, one of America's largest audio networks and the official audio partner of the Nation

    2/5/26 2:29:09 PM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    authID's PrivacyKey™ Delivers Powerful Performance, Delivering 472% Growth in Biometric Enrollments at One of the Largest Global Retailers

    Identity solution scales at more than 5X while delivering exceptional performance at 97% acceptance rate DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:AUID) etc. authID, a leading provider of biometric identity solutions, today announced that a major customer, one of the largest worldwide retailers, is preparing for an expanded rollout of authID's identity platform after reporting strong operational results.  Global retailers face strong threats from deepfakes, AI hack attempts and advanced ransomware, with cyber criminals often infiltrating these victims through social engineering at the help desk. Many large retailers fell victim to such attacks in 2025, with devastating impacts t

    2/5/26 8:00:00 AM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    $ALLR
    $AMV
    $APM
    $AUID
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB DIHYDROCHLORIDE has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 4:31:16 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 11:21:53 AM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 12, 2021 - FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

    For Immediate Release: February 12, 2021 Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer. Cosela may help protect bone marrow cells from damage caused by chemotherapy by inhi

    2/12/21 5:24:11 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AMV
    $APM
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Barisoni Dario

    5 - Nuburu, Inc. (0001814215) (Issuer)

    2/5/26 6:14:50 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Barisoni Dario

    3 - Nuburu, Inc. (0001814215) (Issuer)

    2/5/26 6:12:27 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 5 filed by Taylor Shawn

    5 - Nuburu, Inc. (0001814215) (Issuer)

    2/5/26 5:45:08 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    $ALLR
    $AMV
    $APM
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    Vertical Aerospace Selects Evolito as Electric Propulsion Unit Partner for Valo

    Evolito to supply electric propulsion units for Valo, Vertical's commercial aircraft Companies to jointly certify the electric engines with UK CAA and EASA Evolito joins Honeywell, Syensqo and Aciturri as key suppliers, strengthening Valo's path to commercialization Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced a new long-term partnership with Evolito, a leader in high-performance electric propulsion systems, to supply electric propulsion units ("EPUs") - electric engines - that will power Valo, Vertical's commercial eVTOL aircraft. This press release features multimedia. V

    2/5/26 4:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    CISO Global Partners with TeleDental to Launch CyberSimple® Powered by CHECKLIGHT® to Protect Dental Clinics From Cyber Threats

    Scottsdale, AZ, Jan. 15, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced a strategic partnership with TeleDental.com and DentalChat.com to offer Cyber Assurance Group's CyberSimple® powered by CHECKLIGHT®, delivering cybersecurity and financial protection purpose-built for dental practices. Through this collaboration, CyberSimple® powered by CHECKLIGHT® will be made available via TeleDental.com and DentalChat.com, initially extending protection to more than 358 dental clinics nationwide, with significant expansion potential across the broader U.S. dental market. This effort underline

    1/15/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    Cumulus Media Appoints Carol Flaton to Board of Directors

    ATLANTA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (OTCQB:CMLS) today announced the appointment of Carol Flaton to its Board of Directors. Flaton's appointment follows the resignation of Joan Hogan Gillman from the Board. Both changes are effective January 15, 2026. "We are pleased to welcome Carol to our board," said Chairman Andrew W. Hobson. "She brings more than three decades of experience in financial services and governance, along with a strong track record of advising companies and serving on boards across a wide range of industries. Her insight and financial acumen will further strengthen the Board as the Company continues to execute its strategy." Hobson added, "We th

    1/15/26 8:01:00 AM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    $ALLR
    $AMV
    $APM
    $AUID
    Financials

    Live finance-specific insights

    View All

    Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

    MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast with KOLs and Ocugen executive leadership to discuss data from the first half of patients completing one year since treatment in the OCU410 Phase 2 ArMaDa clinical trial at 8:30 a.m. ET on Thursday, January 15, 2026. Study investigators leading the webcast include: Arshad M. Khanani, MD, MA, FASRS, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Professor at the University of Nevada, Reno School

    1/13/26 7:00:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    LGHL Announces Acquisition of Bitcoin Following the Subsequent Closing under $600 Million Facility

    SINGAPORE, Dec. 11, 2025 /PRNewswire/ -- Lion Group Holding Ltd. (NASDAQ:LGHL) ("LGHL" or the "Company"), a leading operator of an all-in-one trading platform, today announced the acquisition of 88.49 units of Bitcoin (BTC) in $8 million, following the closing of its previously announced subsequent transaction under a convertible note facility, as part of its ongoing strategy to diversify and strengthen its digital assets treasury. This move underscores LGHL's commitment to positioning Bitcoin as a core reserve asset within its portfolio, capitalizing on its status as the premier digital currency and store of value in the evolving global financial landscape. As of December 11, 2025, LGHL's

    12/11/25 9:15:00 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

    93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell lymphoma in the 3L+ setting83% overall response and 61% complete response rates in cohort comprised predominantly of patients with primary refractory large B-cell lymphoma in the 2L settingManageable safety profile appropriate for outpatient administration; no high-grade CRS and ≤ 5% of patients with Grade ≥ 3 ICANS following dexamethasone prophylaxisLyell management will host an investor webcast with presenting author and ronde-cel investigator Sarah M. Larson, MD, Associate Professor at the David Geffen School of Medicine, University of California, Los Angel

    12/7/25 4:30:00 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AMV
    $APM
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:13:58 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary